Precision Business Insights
Portfolio

 

Research Reports

Global Inherited Retinal Disease Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Inherited Retinal Disease Treatment Market: By Treatment Type (Gene Therapy Treatment, Symptomatic Treatment), By End User (Hospitals, Clinics, Ophthalmic Centers), and Geography

 

Global Inherited Retinal Disease Treatment Market Report Description:

Global inherited retinal disease treatment market report gives comprehensive outlook on inherited retinal disease treatment across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global inherited retinal disease treatment market gives historical, current, and future market sizes (US$ Mn) on the basis of treatment type, end user, and region. This report studies global inherited retinal disease treatment market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global inherited retinal disease treatment market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global inherited retinal disease treatment market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global inherited retinal disease treatment market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global inherited retinal disease treatment products.

 

Global Inherited Retinal Disease Treatment Market:

The global Inherited Retinal Disease Treatment market estimated to be valued US$ XX Mn in 2018 and poised to grow at significant CAGR over 2019-2025 due to increase in prevalence of inherited retinal disease around the globe. Moreover, rise in R&D for the development of newer treatment procedures is expected to propel the inherited retinal disease treatment market over the forecast years.

 

Increase in the Prevalence of Inherited Retinal Disease 

Increase in the prevalence of inherited retinal disease in various countries around the globe is a key factor drive the market over the forecast years. For instance, in U.K approximately 4 of every 10,000 children born are diagnosed with inherited retinal disease and the prevalence rate is increased to 6 out of 10,000 population in below 16 years of age. Moreover, presence of skilled professionals and sophisticated healthcare infrastructure are anticipated to propel the inherited retinal disease treatment market over the forecast timeframe.

 

North America Accounts for Larger Market Revenue Share in Global Inherited Retinal Disease Treatment Market

North America accounted for larger revenue share in global inherited retinal disease treatment market with significant CAGR owing to higher disease treatment seeking rate coupled with higher penetration of treatment options are anticipated to propel the market in North America region. Europe inherited retinal disease treatment market projected to grow at significant rate owing to increase in research and development on newer procedures presence of skilled professionals, and favorable reimbursement policies are expected to enhance the market over the forecast years.

 

Competition Assessment

Key player’s profiles in the global inherited retinal disease treatment market include:

  • Spark Therapeutics (U.S.)
  • Novartis AG (Switzerland)
  • Janssen Pharmaceutical Company (Belgium)
  • MeiraGTx Holdings (U.S.)

 

Global inherited retinal disease treatment market is surging owing to collaborations and launch of treatment procedures by the market players. For instance, In January 2019, Janssen Pharmaceutical Company entered into a collaboration and license agreement with MeiraGTx to develop gene therapy programs for inherited retinal diseases. Moreover, In November 2018, Novartis AG received EU approval for one-time gene therapy Luxturna to restore vision in people with rare inherited retinal disease

 

Key Findings of the Report:

 

  • Global inherited retinal disease treatment market expanding at significant CAGR over 2019 to 2025 owing to increase in the prevalence of inherited retinal disease.
  • Based on treatment, gene therapy treatment accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global inherited retinal disease treatment market

 

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2014-2018) and forecast (2019-2025)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Detailed Segmentation

 

By Treatment Type

  • Gene Therapy Treatment
  • Symptomatic Treatment

By End User

  • Hospitals
  • Clinics
  • Ophthalmic Centers

Geography

 

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America
  • Middle East and Africa (MEA)
  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

 

 

Table of Content

  1. Executive Summary
  2. Global Inherited Retinal Disease Market Introduction
    • Global Inherited Retinal Disease Market – Taxonomy
    • Global Inherited Retinal Disease Market –Definitions
      • Treatment Type
  1. Global Inherited Retinal Disease Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Inherited Retinal Disease Market Dynamic Factors – Impact Analysis
    • Global Inherited Retinal Disease Market – Competition Landscape
    • Epidemiology
  2. Global Inherited Retinal Disease Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Inherited Retinal Disease Market, By Treatment Type, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Gene Therapy Treatment
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Symptomatic Treatment
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Inherited Retinal Disease Market Forecast, By End User, 2014 – 2018 and Forecast, 2019 – 2025
    • Hospitals
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Clinics
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ophthalmic Centers
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Inherited Retinal Disease Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Inherited Retinal Disease Market – Opportunity Analysis Index, By Treatment Type, By End User, and Region, 2019 – 2025
  2. North America Inherited Retinal Disease Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Treatment Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gene Therapy Treatment
      • Symptomatic Treatment
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Ophthalmic Centers
    • Country Analysis 2016 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Inherited Retinal Disease Market – Opportunity Analysis Index, By Treatment Type, By End User, and Country, 2019 – 2025
    • North America Inherited Retinal Disease Market Dynamics – Trends
  3. Europe Inherited Retinal Disease Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Treatment Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gene Therapy Treatment
      • Symptomatic Treatment
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Ophthalmic Centers
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Inherited Retinal Disease Market – Opportunity Analysis Index, By Treatment Type, By End User, and Country,2019 – 2025
    • Europe Inherited Retinal Disease Market Dynamics – Trends
  4. Asia-Pacific Inherited Retinal Disease Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Treatment Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gene Therapy Treatment
      • Symptomatic Treatment
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Ophthalmic Centers
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Inherited Retinal Disease Market – Opportunity Analysis Index, By Treatment Type, By End User, and Country,2019 – 2025
    • Asia-Pacific Inherited Retinal Disease Market Dynamics – Trends
  5. Latin America Inherited Retinal Disease Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Treatment Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gene Therapy Treatment
      • Symptomatic Treatment
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Ophthalmic Centers
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Inherited Retinal Disease Market – Opportunity Analysis Index, By Treatment Type, By End User, and Country, 2019 – 2025
    • Latin America Inherited Retinal Disease Market Dynamics – Trends
  6. Middle East and Africa Inherited Retinal Disease Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Treatment Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gene Therapy Treatment
      • Symptomatic Treatment
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Ophthalmic Centers
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Inherited Retinal Disease Market – Opportunity Analysis Index, By Treatment Type, By End User, and Country, 2019 – 2025
    • MEA Inherited Retinal Disease Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Treatment Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Spark Therapeutics (U.S.)
      • Novartis AG (Switzerland)
      • Janssen Pharmaceutical Company (Belgium)
      • MeiraGTx Holdings (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

 

Contact SalesTOLL FREE: +1-866-598-1553